Abciximab biosimilar - PfenexAlternative Names: Monoclonal antibody 7E3 - Pfenex
Latest Information Update: 02 Jun 2015
At a glance
- Originator Pfenex
- Class Antiplatelets; Fab fragments; Ischaemic heart disorder therapies; Monoclonal antibodies
- Mechanism of Action GPIIb-IIIa antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Vascular disorders
Most Recent Events
- 01 Jan 2015 No development reported for Vascular disorders in USA (IV)